Keyuan Pharma made a shining appearance at CPHI Milan 2024, adding new impetus to internationalization journey!

       From October 8th to 10th, CPHI Milan 2024 (Chemical Pharmaceutical Ingredient International Exhibition), the focus event of the global pharmaceutical industry, opened grandly in Milan, Italy. The exhibition brought together pharmaceutical raw material suppliers, manufacturers, R&D institutions and professional audiences from all over the world to discuss new trends, new challenges and new opportunities in the development of the pharmaceutical industry.

       As a leading company in the domestic chemical API segment, Keyuan Pharma (stock code: 301281.SZ) was invited to participate in this exhibition, showing outstanding scientific research strength and forward-looking international layout.

       Since its establishment in 2004, Keyuan Pharma has accumulated profound competitive advantages in key diseases such as anti-diabetic, anesthetic, cardiovascular and psychiatric. All products have passed the China GMP certification, the core products have the EU CEP certificate, and have successively passed the US FDA, Japan PMDA, South Korea MFDS and other official drug administration certifications, making Keyuan Pharma steady on the road of internationalization.

       At the CPHI Milan 2024 exhibition, the overall color of the booth of Keyuan Pharma is science blue and medical white, the booth attracted many new and old customers to watch and consult. The core products on display not only demonstrated Keyuan Pharma's deep accumulation in the pharmaceutical field, but also reflected its outstanding strength in technological innovation and quality assurance.

       During the exhibition, Keyuan Pharma's international marketing team had in-depth discussions and exchanges on products with partners from all over the world, deepened strategic cooperation with old customers, and attracted more potential customers, further promoting comprehensive development in R&D, production, sales, etc., enhancing international influence and competitiveness in the global pharmaceutical market, and promoting new achievements in international strategic operations.

       When the exhibition came to an end, Keyuan Pharma embarked on the return journey with full harvest and hope. But this long-distance pharmaceutical journey has not ended, it is just a new starting point in Keyuan's internationalization journey.

       Keyuan Pharma will take this exhibition as an opportunity to deepen its roots in the pharmaceutical industry, strengthen lean production, consolidate competitive advantages, actively expand overseas markets with firm determination and a new attitude, continue to strengthen communication and cooperation with international partners, and promote new breakthroughs in performance.